x
Filter:
Filters applied
- JLR Patient-Oriented and Epidemiological Research
- cholesterolRemove cholesterol filter
- diet and dietary lipidsRemove diet and dietary lipids filter
JLR Patient-Oriented and Epidemiological Research
2 Results
- Patient-Oriented and Epidemiological ResearchOpen Access
Macronutrient-specific effect of the MTNR1B genotype on lipid levels in response to 2 year weight-loss diets
Journal of Lipid ResearchVol. 59Issue 1p155–161Published online: October 31, 2017- Leticia Goni
- Dianjianyi Sun
- Yoriko Heianza
- Tiange Wang
- Tao Huang
- Marta Cuervo
- and others
Cited in Scopus: 14Compelling evidence indicates that lipid metabolism is in partial control of the circadian system. In this context, it has been reported that the melatonin receptor 1B (MTNR1B) genetic variant influences the dynamics of melatonin secretion, which is involved in the circadian system as a chronobiotic. The objective was to analyze whether the MTNR1B rs10830963 genetic variant was related to changes in lipid levels in response to dietary interventions with different macronutrient distribution in 722 overweight/obese subjects from the POUNDS Lost trial. - Patient-Oriented and Epidemiological ResearchOpen Access
Lipidomic changes of LDL in overweight and moderately hypercholesterolemic subjects taking phytosterol- and omega-3-supplemented milk
Journal of Lipid ResearchVol. 56Issue 5p1043–1056Published online: March 15, 2015- Teresa Padro
- Gemma Vilahur
- Joan Sánchez-Hernández
- Marta Hernández
- Rosa M. Antonijoan
- Antonio Perez
- and others
Cited in Scopus: 21The benefits of dietary phytosterols (PhySs) and long-chain n-3 PUFA (ω3) have been linked to their effects as cholesterol- and triglyceride (TGL)-lowering agents. However, it remains unknown whether these compounds have further metabolic effects on LDL lipid composition. Here, we studied the effects of PhyS- or ω3-supplemented low-fat milk (milk) on the LDL-lipidome. Overweight and moderately hypercholesterolemic subjects (n = 32) were enrolled in a two-arm longitudinal crossover study. Milk (250 ml/day), enriched with either 1.57 g PhyS or 375 mg ω3 (EPA + DHA), was given to the participants during two sequential 28 day intervention periods.